| 1 | Receive the Annual Report | For |
| 2 | Approve the Remuneration Report | Oppose |
| 3 | Approve Remuneration Policy | Oppose |
| 4 | Approve the Dividend | For |
| 5 | Re-elect Sir Dave Lewis - Chair (Non Executive) | For |
| 6 | Re-elect Brian McNamara - Chief Executive | For |
| 7 | Re-elect Tobias Hestler - Executive Director | For |
| 8 | Re-elect Manvinder Singh Vindi Banga - Senior Independent Director | For |
| 9 | Re-elect Marie-Anne Aymerich - Non-Executive Director | For |
| 10 | Re-elect Tracy Clarke - Non-Executive Director | For |
| 11 | Re-elect Dame Vivienne Cox - Designated Non-Executive | For |
| 12 | Re-elect Asmita Dubey - Non-Executive Director | For |
| 13 | Re-elect Deirdre Mahlan - Non-Executive Director | For |
| 14 | Elect David Denton - Non-Executive Director | For |
| 15 | Re-elect Bryan Supran - Non-Executive Director | For |
| 16 | Appoint KPMG LLP as Auditor of the Company | For |
| 17 | Authorize the Audit & Risk Committee to determine the remuneration of the Auditor on behalf of the Board. | For |
| 18 | Approve Political Donations | For |
| 19 | Issue Shares with Pre-emption Rights | For |
| 20 | Issue Shares for Cash | For |
| 21 | Issue Shares for Cash for the Purpose of Financing an Acquisition or Other Capital Investment | Oppose |
| 22 | Meeting Notification-related Proposal | For |
| 23 | Approve the Performance Share Plan | Oppose |
| 24 | Approve the Share Value Plan | For |
| 25 | Approve the Deferred Annual Bonus Plan | Oppose |
| 26 | Authorise On-Market purchases of own shares | For |
| 27 | Authority to make off-market purchases of own shares from Pfizer | For |
| 28 | Authority to make off-market purchases of own shares from GSK Shareholders | For |
| 29 | Approve the Waiver of Rule 9 offer Obligation | For |
